DeepHealth is introducing in Europe its cloud-first integrated portfolio combining clinical AI, multi-modality viewing and reporting, which is designed to improve outcomes, efficiency and access to ca ...
Alam frames PHI and MRI as noninvasive tools that help refine risk before proceeding to biopsy. In this video, Ridwan I. Alam, MD, MPH, discusses how the Prostate Health Index (PHI) performs alongside ...
Introduction: The BIOPSTAGE trial investigates the added diagnostic value of combining prostate-specific membrane antigen positron emission tomography (PSMA PET) with multiparametric MRI (mpMRI) for ...
ABSTRACT: Introduction: Prostate cancer (PC) is a malignant proliferation of prostate cells. Common screening methods, such as digital rectal examination and prostate-specific antigen (PSA) testing, ...
Purpose: The accurate diagnosis of prostate cancer (PCa) remains challenging, particularly because standard biopsy techniques do not routinely include anterior zone, leading to potential missed ...
Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...
At the IURES 2025 Congress, researchers presented new findings demonstrating the feasibility and diagnostic value of adding seminal vesicle sampling to transperineal prostate biopsy (TP-Bx) procedures ...
We performed a post hoc analysis of a single-center phase II trial (ClinicalTrials.gov identifier: NCT03503643) in which patients with unilateral grade group (GG) 2-4 PCa (n = 108) underwent hemigland ...
Objective: To evaluate the diagnostic value of prostate-specific antigen (PSA) density, digital rectal examination (DRE), and family history in predicting prostate cancer among patients with low-risk ...
Patients with ≥1 MRI lesion who underwent both transperineal 12-core and 3-core TB were enrolled in this study. Detection rates for total prostate cancer (PCa) and clinically significant PCa (csPCa) ...
Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...
MRI should be considered an adjunct to, and not a replacement for, biopsies for men on active surveillance for prostate cancer. MRI does not consistently rule out the presence of Gleason grade group 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results